[{"id":"80aeebc4-d0de-4187-be00-eb2d58e0ac3d","acronym":"","url":"https://clinicaltrials.gov/study/NCT04903873","created_at":"2021-05-27T13:53:05.902Z","updated_at":"2024-07-02T16:35:14.549Z","phase":"Phase 1/2","brief_title":"A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors","source_id_and_acronym":"NCT04903873","lead_sponsor":"Eutilex","biomarkers":" ALK • MSI • ROS1","pipe":" | ","alterations":" MSI-H/dMMR • RAS mutation","tags":["ALK • MSI • ROS1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSI-H/dMMR • RAS mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EU101"],"overall_status":"Recruiting","enrollment":" Enrollment 110","initiation":"Initiation: 05/31/2021","start_date":" 05/31/2021","primary_txt":" Primary completion: 09/01/2025","primary_completion_date":" 09/01/2025","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2024-03-15"}]